Geneos Wealth Management’s Astera Labs ALAB Stock Holding History

Geneos Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.5M	Buy	4,209 +943	+29%	+$303K	0.03%	475
2026 Q2	$1.58M	Sell	3,266 -4,789	-59%	-$1.27M	0.03%	435
2026 Q1	$883K	Buy	8,055 +204	+3%	+$29.1K	0.02%	541
2025 Q4	$1.31M	Buy	7,851 +381	+5%	+$63.7K	0.03%	436
2025 Q3	$1.46M	Sell	7,470 -1,450	-16%	-$238K	0.04%	405
2025 Q2	$807K	Buy	8,920 +4,887	+121%	+$386K	0.02%	587
2025 Q1	$241K	Buy	4,033 +3,761	+1,383%	+$348K	0.01%	845
2024 Q4	$36K	Buy	+272	New	+$25.5K	﹤0.01%	1449

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Geneos Wealth Management's ALAB Position: Q3 2026 in Review

Geneos Wealth Management increased its Astera Labs (ALAB) stake by 29% in Q3 2026, buying an estimated $303K and bringing the position to 4,209 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #475.

Geneos Wealth Management first reported a position in ALAB in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2026. 544 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Geneos Wealth Management held 4,209 shares of Astera Labs worth $1.5M as of Q3 2026.
Geneos Wealth Management bought 943 Astera Labs shares in Q3 2026, an estimated $303K.
Astera Labs made up 0.03% of Geneos Wealth Management's portfolio in Q3 2026, its #475 holding.
Geneos Wealth Management first reported a position in Astera Labs in Q4 2024 and has held it in 8 quarters since.
Geneos Wealth Management's Astera Labs position peaked at $1.58M in Q2 2026.
544 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.